APA aipamena

Takahashi, Y., Eguchi, T., Bains, S., & Adusumilli, P. S. (2016). Significance of IASLC/ATS/ERS classification for early-stage lung adenocarcinoma patients in predicting benefit from adjuvant chemotherapy. Ann Transl Med.

Chicago Style aipamena

Takahashi, Yusuke, Takashi Eguchi, Sarina Bains, and Prasad S. Adusumilli. "Significance of IASLC/ATS/ERS Classification for Early-stage Lung Adenocarcinoma Patients in Predicting Benefit From Adjuvant Chemotherapy." Ann Transl Med 2016.

MLA aipamena

Takahashi, Yusuke, Takashi Eguchi, Sarina Bains, and Prasad S. Adusumilli. "Significance of IASLC/ATS/ERS Classification for Early-stage Lung Adenocarcinoma Patients in Predicting Benefit From Adjuvant Chemotherapy." Ann Transl Med 2016.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.